Your browser doesn't support javascript.
loading
Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma.
Lee, Jake June-Koo; Park, Seongyeol; Park, Hansol; Kim, Sehui; Lee, Jongkeun; Lee, Junehawk; Youk, Jeonghwan; Yi, Kijong; An, Yohan; Park, In Kyu; Kang, Chang Hyun; Chung, Doo Hyun; Kim, Tae Min; Jeon, Yoon Kyung; Hong, Dongwan; Park, Peter J; Ju, Young Seok; Kim, Young Tae.
Affiliation
  • Lee JJ; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, United States; Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, United Stat
  • Park S; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.
  • Park H; Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.
  • Kim S; Department of Pathology, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Lee J; Clinical Genomics Analysis Branch, National Cancer Center, Goyang 10408, Korea.
  • Lee J; Korea Institute of Science and Technology Information, Daejeon 34141, Korea.
  • Youk J; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.
  • Yi K; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.
  • An Y; Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea.
  • Park IK; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Korea.
  • Kang CH; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Korea.
  • Chung DH; Department of Pathology, Seoul National University College of Medicine, Seoul 03080, Korea.
  • Kim TM; Seoul National University Cancer Research Institute, Seoul 03080, Korea; Department of Internal Medicine, Seoul National University Hospital, Seoul 03080, Korea.
  • Jeon YK; Department of Pathology, Seoul National University College of Medicine, Seoul 03080, Korea; Seoul National University Cancer Research Institute, Seoul 03080, Korea.
  • Hong D; Clinical Genomics Analysis Branch, National Cancer Center, Goyang 10408, Korea.
  • Park PJ; Department of Biomedical Informatics, Harvard Medical School, Boston, MA 02115, United States; Ludwig Center at Harvard, Harvard Medical School, Boston, MA 02115, United States.
  • Ju YS; Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea; Biomedical Science and Engineering Interdisciplinary Program, Korea Advanced Institute of Science and Technology, Daejeon 34141, Korea. Electronic address: ysju@kaist.ac.kr.
  • Kim YT; Department of Thoracic and Cardiovascular Surgery, Seoul National University Hospital, Seoul 03080, Korea; Seoul National University Cancer Research Institute, Seoul 03080, Korea. Electronic address: ytkim@snu.ac.kr.
Cell ; 177(7): 1842-1857.e21, 2019 06 13.
Article in En | MEDLINE | ID: mdl-31155235
ABSTRACT
Mutational processes giving rise to lung adenocarcinomas (LADCs) in non-smokers remain elusive. We analyzed 138 LADC whole genomes, including 83 cases with minimal contribution of smoking-associated mutational signature. Genomic rearrangements were not correlated with smoking-associated mutations and frequently served as driver events of smoking-signature-low LADCs. Complex genomic rearrangements, including chromothripsis and chromoplexy, generated 74% of known fusion oncogenes, including EML4-ALK, CD74-ROS1, and KIF5B-RET. Unlike other collateral rearrangements, these fusion-oncogene-associated rearrangements were frequently copy-number-balanced, representing a genomic signature of early oncogenesis. Analysis of mutation timing revealed that fusions and point mutations of canonical oncogenes were often acquired in the early decades of life. During a long latency, cancer-related genes were disrupted or amplified by complex rearrangements. The genomic landscape was different between subgroups-EGFR-mutant LADCs had frequent whole-genome duplications with p53 mutations, whereas fusion-oncogene-driven LADCs had frequent SETD2 mutations. Our study highlights LADC oncogenesis driven by endogenous mutational processes.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Rearrangement / Oncogene Proteins, Fusion / Adenocarcinoma of Lung / Lung Neoplasms / Mutation Limits: Female / Humans / Male Language: En Journal: Cell Year: 2019 Type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Gene Rearrangement / Oncogene Proteins, Fusion / Adenocarcinoma of Lung / Lung Neoplasms / Mutation Limits: Female / Humans / Male Language: En Journal: Cell Year: 2019 Type: Article